GLPBio

Immunology/Inflammation

Read More about this category

The immune and inflammation-related pathway including the Toll-like receptors pathway, the B cell receptor signaling pathway, the T cell receptor signaling pathway, etc.

Toll-like receptors (TLRs) play a central role in host cell recognition and responses to microbial pathogens. TLR4 initially recruits TIRAP and MyD88. MyD88 then recruits IRAKs, TRAF6, and the TAK1 complex, leading to early-stage activation of NF-κB and MAP kinases [1]. TLR4 is endocytosed and delivered to intracellular vesicles and forms a complex with TRAM and TRIF, which then recruits TRAF3 and the protein kinases TBK1 and IKKi. TBK1 and IKKi catalyze the phosphorylation of IRF3, leading to the expression of type I IFN [2].

BCR signaling is initiated through ligation of mIg under conditions that induce phosphorylation of the ITAMs in CD79, leading to the activation of Syk. Once Syk is activated, the BCR signal is transmitted via a series of proteins associated with the adaptor protein B-cell linker (Blnk, SLP-65). Blnk binds CD79a via non-ITAM tyrosines and is phosphorylated by Syk. Phospho-Blnk acts as a scaffold for the assembly of the other components, including Bruton’s tyrosine kinase (Btk), Vav 1, and phospholipase C-gamma 2 (PLCγ2) [3]. Following the assembly of the BCR-signalosome, GRB2 binds and activates the Ras-guanine exchange factor SOS, which in turn activates the small GTPase RAS. The original RAS signal is transmitted and amplified through the mitogen-activated protein kinase (MAPK) pathway, which including the serine/threonine-specific protein kinase RAF followed by MEK and extracellular signal related kinases ERK 1 and 2 [4]. After stimulation of BCR, CD19 is phosphorylated by Lyn. Phosphorylated CD19 activates PI3K by binding to the p85 subunit of PI3K and produce phosphatidylinositol-3,4,5-trisphosphate (PIP3) from PIP2, and PIP3 transmits signals downstream [5].

Central process of T cells responding to specific antigens is the binding of the T-cell receptor (TCR) to specific peptides bound to the major histocompatibility complex which expressed on antigen-presenting cells (APCs). Once TCR connected with its ligand, the ζ-chain–associated protein kinase 70 molecules (Zap-70) are recruited to the TCR-CD3 site and activated, resulting in an initiation of several signaling cascades. Once stimulation, Zap-70 forms complexes with several molecules including SLP-76; and a sequential protein kinase cascade is initiated, consisting of MAP kinase kinase kinase (MAP3K), MAP kinase kinase (MAPKK), and MAP kinase (MAPK) [6]. Two MAPK kinases, MKK4 and MKK7, have been reported to be the primary activators of JNK. MKK3, MKK4, and MKK6 are activators of P38 MAP kinase [7]. MAP kinase pathways are major pathways induced by TCR stimulation, and they play a key role in T-cell responses.

Phosphoinositide 3-kinase (PI3K) binds to the cytosolic domain of CD28, leading to conversion of PIP2 to PIP3, activation of PKB (Akt) and phosphoinositide-dependent kinase 1 (PDK1), and subsequent signaling transduction [8].

 

References

[1] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors[J]. Nature immunology, 2010, 11(5): 373-384.

[2] Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity[J]. Immunity, 2011, 34(5): 637-650.

[3] Packard T A, Cambier J C. B lymphocyte antigen receptor signaling: initiation, amplification, and regulation[J]. F1000Prime Rep, 2013, 5(40.10): 12703.

[4] Zhong Y, Byrd J C, Dubovsky J A. The B-cell receptor pathway: a critical component of healthy and malignant immune biology[C]//Seminars in hematology. WB Saunders, 2014, 51(3): 206-218.

[5] Baba Y, Matsumoto M, Kurosaki T. Calcium signaling in B cells: regulation of cytosolic Ca 2+ increase and its sensor molecules, STIM1 and STIM2[J]. Molecular immunology, 2014, 62(2): 339-343.

[6] Adachi K, Davis M M. T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells[J]. Proceedings of the National Academy of Sciences, 2011, 108(4): 1549-1554.

[7] Rincón M, Flavell R A, Davis R A. The Jnk and P38 MAP kinase signaling pathways in T cell–mediated immune responses[J]. Free Radical Biology and Medicine, 2000, 28(9): 1328-1337.

[8] Bashour K T, Gondarenko A, Chen H, et al. CD28 and CD3 have complementary roles in T-cell traction forces[J]. Proceedings of the National Academy of Sciences, 2014, 111(6): 2241-2246.

Research Areas

Products Related to Immunology/Inflammation(4435)

  • GC10451 structure
    GC10451U-73122
    CAS: 112648-68-7
    Purity: >98.00%

    U-73122 es un inhibidor potente y selectivo de la fosfolipasa C (PLC) con un valor de IC50 de aproximadamente 1-2.1 μM. También inhibe la 5-lipoxigenasa (5-LO).

  • GC10692 structure
    GC10692Caffeic Acid Phenethyl Ester
    CAS: 104594-70-9
    Purity: >98.00%

    Caffeic Acid Phenethyl Ester es un compuesto fenilpropanoide natural presenta en los propóleos, que posee diversas actividades biológicas

  • GC10712 structure
    GC10712Imiquimod hydrochloride
    CAS: 99011-78-6
    Purity: >99.50%

    El clorhidrato de imiquimod (clorhidrato de R 837), un modificador de la respuesta inmunitaria, es un agonista selectivo del receptor tipo toll 7 (TLR7).

  • GC10933 structure
    GC10933Sodium 4-Aminosalicylate
    CAS: 6018-19-5
    Purity: >99.50%

    El 4-aminosalicilato de sodio (sal sÓdica dihidratada del Ácido 4-aminosalicÍlico) es uno de los fÁrmacos antimicobacterianos utilizados actualmente para la tuberculosis multirresistente.

  • GC11438 structure
    GC11438JSH-23
    CAS: 749886-87-1
    Purity: >98.00%

    JSH-23, mostró un efecto inhibidor en la translocación nuclear y en la actividad transcripcional de NF-κB con un valor de IC50 de 7,1 μM en macrófagos RAW 264.7 estimulados con lipopolisacáridos (LPS).

  • GC11719 structure
    GC11719HG-9-91-01
    CAS: 1456858-58-4
    Purity: >99.00%

    HG-9-91-01 es un inhibidor de quinasas inducibles por sal (SIK), que inhibe SIK1, SIK2 y SIK3 con valores de IC50 de 0.92nM, 6.5nM y 19.4nM, respectivamente.

  • GC11819 structure
    GC11819Strontium Ranelate
    CAS: 135459-87-9
    Purity: >99.50%

    El ranelato de estroncio (S12911) es un agente antiosteoporÓtico que actÚa reduciendo la reabsorciÓn Ósea y promoviendo la formaciÓn Ósea, induciendo asÍ un balance Óseo positivo.

  • GC12013 structure
    GC12013Sodium salicylate
    CAS: 54-21-7
    Purity: >99.50%

    El salicilato de sodio (sal de sodio del Ácido salicÍlico) inhibe la actividad de la ciclooxigenasa-2 (COX-2) independientemente de la activaciÓn del factor de transcripciÓn (NF-κB).

  • GC12180 structure
    GC12180IKK-16 (IKK Inhibitor VII)
    CAS: 873225-46-8
    Purity: >99.00%

    IKK-16 (IKK Inhibitor VII) es un inhibidor selectivo nuevo y activo por vía oral de la quinasa IκB (IKK). Muestra valores de IC₅₀ de 40nM, 70nM y 200nM para IKK-2, IKK y IKK-1

  • GC12645 structure
    GC12645Imiquimod maleate
    CAS: 896106-16-4
    Purity: >98.00%

    El maleato de imiquimod (maleato R 837), un modificador de la respuesta inmunitaria, es un agonista selectivo del receptor tipo toll 7 (TLR7).

  • GC13066 structure
    GC13066Y-320
    CAS: 288250-47-5
    Purity: >99.00%

    Y-320 es un potente inmunomodulador de fenilpirazolanilida activo por vÍa oral.

  • GC13650 structure
    GC13650Resiquimod (R-848)
    CAS: 144875-48-9
    Purity: >99.50%

    Resiquimod (R-848) es un compuesto de imidazoquinolina con potencial actividad antiviral.

  • GC14352 structure
    GC14352TAT 14
    CAS: 1362661-34-4
    Purity: >98.00%

    TAT 14 es un péptido de 14 mer que actúa como activador de Nrf2 con un efecto antiinflamatorio.

  • GC14435 structure
    GC14435Zileuton sodium
    CAS: 118569-21-4
    Purity: >98%

    El zileutÓn sÓdico (A 64077 sÓdico) es un inhibidor potente y selectivo de la 5-lipoxigenasa, que exhibe actividades inflamatorias.

  • GC14438 structure
    GC14438Suprofen
    CAS: 40828-46-4
    Purity: >99.50%

    Suprofen (TN-762) es un fÁrmaco antiinflamatorio no esteroideo (AINE).

  • GC14633 structure
    GC14633HPGDS inhibitor 1
    CAS: 1033836-12-2
    Purity: >99.00%

    El inhibidor 1 de HPGDS es un inhibidor potente, selectivo y oralmente activo de la sintasa hematopoyética D de la prostaglandina (HPGDS) con una IC50 de 0,6 nM y 32 nM en ensayos enzimÁticos y celulares, respectivamente.

  • GC14751 structure
    GC14751Malotilate
    CAS: 59937-28-9
    Purity: >99.50%

    El malotilato (NKK 105), un agente hepatotrÓpico activo por vÍa oral y una sustancia antifibrÓtica, inhibe selectivamente la 5-lipoxigenasa (5-LOX) (IC50 = 4,7 μM). El malotilato previene el desarrollo de lesiÓn hepatocÍtica en la hepatitis por alcohol-pirazol al disminuir los niveles de acetaldehÍdo hepÁtico y prevenir la retenciÓn de transferrina en los hepatocitos.

  • GC16014 structure
    GC16014Zileuton
    CAS: 111406-87-2
    Purity: >99.00%

    Zileuton, un benzotiofeno N-hydroxyurea, es un inhibidor oral de la 5-Lipoxygenase

  • GC16120 structure
    GC16120AI-3
    CAS: 882288-28-0
    Purity: >98%

    Nrf2/Keap1 and Keap1/Cul3 interaction inhibitor

  • GC16148 structure
    GC16148TAK-242
    CAS: 243984-11-4
    Purity: >98.00%

    TAK-242 es un inhibidor de señalización del receptor 4 (TLR4) similar al peaje.

  • GC16590 structure
    GC16590Dimethyl Fumarate
    CAS: 624-49-7
    Purity: >97.00%

    El dimetilfumarato (DMF) es un activador de Nrf2 activo por vÍa oral y que penetra en el cerebro e induce la regulaciÓn positiva de la expresiÓn génica antioxidante.

  • GC16607 structure
    GC16607Mesalamine
    CAS: 89-57-6
    Purity: >98.00%

    El Ácido 5-aminosalicÍlico (mesalamina) actÚa como un PPARγ especÍfico; agonista y también inhibe la quinasa 1 activada por p21 (PAK1) y NF-κB.

  • GC16641 structure
    GC16641ML130 (Nodinitib-1)
    CAS: 799264-47-4
    Purity: >99.50%

    ML130 (Nodinitib-1) (ML130;CID-1088438) es un inhibidor de NOD1 con un IC50 de 0,56 μM.

  • GC16880 structure
    GC16880Flurbiprofen
    CAS: 5104-49-4
    Purity: >99.50%

    El flurbiprofeno (dl-flurbiprofeno) es un potente agente antiinflamatorio no esteroideo activo por vÍa oral (NSAIA/NSAID), con actividades antipiréticas y analgésicas.